Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 144 clinical trials
Observational Registry of Patients With Rheumatoid Arthritis /Spondyloarthritis Using Biological or Targeted Synthetic DMARDs (BioSTaR)

controls in patients with spondyloarthritis and rheumatoid arthritis. It is planned to conduct scientific analyzes and publish on various subjects from the recorded information on this registration system

DMARD
spondyloarthropathy
arthritis
psoriatic arthritis
antirheumatics
  • 4 views
  • 15 Feb, 2022
  • 11 locations
PANLAR's Latin American Registry of Rheumatic Patients Treated With Jak Inhibitors

This prospective, non-interventional, research registry is designed to study the comparative safety and comparative effectiveness of approved Jak Inhibitors treatment for RA-PsA-SpA in a cohort of patients and theirs controls cared for by rheumatologists across Latin Amrica (LA).

  • 0 views
  • 05 Apr, 2021
  • 2 locations
Biobank for Inflammatory Chronic Diseases and Osteoporosis

arthritis (RA), spondyloarthritis(SpA), and psoriatic arthritis (PsA) or a chronic bone disease including osteoporosis in order to identify biomarkers associated with therapeutic response.

rheumatism
arthritis
secondary osteoporosis
psoriatic arthritis
osteoporosis
  • 0 views
  • 26 Sep, 2021
  • 1 location
ATI Evidence-based Guide Investigating Clinical Services (AEGIS)

The investigators goal is to provide a mechanism that allows for a better understanding of patient outcomes following rehabilitation. This includes functional outcomes measured by standardized and validated tools from the published literature. It incorporates comorbidities and patient demographic characteristics. It includes measures of general health as well along with …

treatment guidelines
Accepts healthy volunteers
  • 93 views
  • 24 Jan, 2022
  • 1 location
Evolution and Treatments of Chronic Inflammatory Systemic Diseases (MISTIC)

are inflammatory bowel diseases (IBD - Crohn's disease [MC] and ulcerative colitis [RCH]), and chronic inflammatory rheumatic diseases (rheumatoid arthritis [RA] and spondyloarthritis [SpA] including

rheumatism
ankylosing spondylitis
arthritis
rheumatoid arthritis
crohn's disease
  • 0 views
  • 25 Feb, 2022
  • 1 location
Observational Study in Patients Treated With JAK Inhibitors for Inflammatory Rheumatism (MAJIK)

Janus kinase (JAK) inhibitors are a new class of molecules available to the therapeutic arsenal for chronic inflammatory rheumatic diseases.The tolerance profile of this new class needs to be better defined and its use in real life further established. The French Society of Rheumatologists intends to coordinate a prospective national …

rheumatism
arthritis
rheumatic diseases
psoriatic arthritis
rheumatoid arthritis
  • 3 views
  • 05 Aug, 2021
  • 56 locations
A Study of the Change in Early and Sustained Pain Control in Radiographic Axial Spondylarthritis in Adult Participants Receiving Upadacitinib (UPSTAND)

Axial spondyloarthritis (axSpA) is an immune-mediated inflammatory disease primarily affecting the axial skeleton. The most frequent axSpA symptom is chronic, often inflammatory back pain (IBP

  • 7 views
  • 24 Jul, 2022
  • 66 locations
Pregnancy and Medically Assisted Conception in Rare Diseases

Rare diseases frequently affect women of childbearing age. Pregnancy in these women has become less rare, but remains associated with high levels of complications. One obstacle to their optimal management during pregnancy is that there are no prospective studies of pregnancy during rare diseases and several connective tissue diseases. As …

sjogren's syndrome
human chorionic gonadotrophin
rheumatic diseases
myositis
beta-hcg
  • 239 views
  • 13 May, 2021
  • 2 locations
Italian Registry of Arthritis on Biologic Therapy (GISEA)

clinical data of patients with rheumatoid arthritis and spondyloarthritis beginning a treatment with biologic drugs in order to assess the long-term safety and efficacy in the real life.

ankylosing spondylitis
psoriatic arthritis
tumor necrosis factor alpha
methotrexate
spondyloarthropathy
  • 7 views
  • 01 Mar, 2022
  • 1 location
Identification of New Biomarkers to Promote Personalized Treatment of Patients With Inflammatory Rheumatic Diseases

Introduction: The medical treatment of inflammatory rheumatic diseases has improved dramatically during the last decades primarily due to the introduction of biological disease modifying anti-rheumatic drugs (bDMARDs). However, bDMARD treatment failure occurs in 30-40% of patients due to lack of effectiveness or side effects. The tools to predict treatment outcomes …

arthritis
psoriatic arthritis
edta
rheumatoid arthritis
DMARD
  • 305 views
  • 24 Jan, 2021
  • 12 locations